Evidence map›Paper›PMID 35381860›Full record

ArticlePediatric cardiology2022

Palliation Strategy to Achieve Complete Repair in Symptomatic Neonates with Tetralogy of Fallot.

Mark A Law, Andrew C Glatz, Jennifer C Romano, Paul J Chai, Christopher E Mascio, Christopher J Petit, Courtney E McCracken, Michael S Kelleman, George T Nicholson, Jeffery J Meadows and 9 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Mark A LawDepartment of Pediatrics, University of Alabama at Birmingham, 1700 6th Ave S, Suite 9100, Birmingham, AL, 35233, USA. mlaw@uabmc.edu.ORCID http://orcid.org/0000-0003-0690-9779
Andrew C GlatzCardiac Center, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Jennifer C RomanoC.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, Atlanta, USA.
Paul J ChaiChildren's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
Christopher E MascioCardiac Center, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Christopher J PetitColumbia University Irving Medical Center, New York, NY, USA.
Courtney E McCrackenChildren's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
Michael S KellemanChildren's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
George T NicholsonDivision of Cardiology, Monroe Carrell Jr. Children's Hospital, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jeffery J MeadowsDepartment of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Jeffrey D ZampiC.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI, Atlanta, USA.
Shabana ShahanavazDepartment of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Sarosh P BatlivalaDepartment of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Joelle PettusChildren's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA.
Amy L PajkDepartment of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Kristal M HockDepartment of Pediatrics, University of Alabama at Birmingham, 1700 6th Ave S, Suite 9100, Birmingham, AL, 35233, USA.ORCID http://orcid.org/0000-0002-4301-3616
Bryan H GoldsteinDepartment of Pediatrics, Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Athar M QureshiDepartment of Pediatrics, Lillie Frank Abercrombie Section on Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Congenital Cardiac Research Collaborative (CCRC) Investigators
Cincinnati Children's Hospital Medical Center · USEmory University · USChildren's Hospital of Philadelphia · USMonroe Carell Jr. Children's Hospital · USUniversity of Alabama at Birmingham · USUniversity of Michigan · USBaylor College of Medicine · USColumbia University Irving Medical Center · USUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neonates with symptomatic tetralogy of Fallot (sTOF) may undergo palliations with varying physiology, namely systemic to pulmonary artery connections (SPC) or right ventricular outflow tract interventions (RVOTI). A comparison of palliative strategies based on the physiology created is lacking. Consecutive sTOF neonates undergoing SPC or RVOTI from 2005-2017 were reviewed from the Congenital Cardiac Research Collaborative. The primary outcome was survival with successful complete repair (CR) by 18 months. A variety of secondary outcomes were assessed including overall survival, hospitalization-related comorbidities, and interstage reinterventions. Propensity score adjustment was utilized to compare treatment strategies. The cohort included 252 SPC (surgical shunt = 226, ductus arteriosus stent = 26) and 68 RVOTI (balloon pulmonary valvuloplasty = 48, RVOT stent = 11, RVOT patch = 9) patients. Genetic syndrome (29 [42.6%] v 75 [29.8%], p = 0.04), weight < 2.5 kg (28 [41.2%] v 68 [27.0%], p = 0.023), bilateral pulmonary artery Z-score < - 2 (19 [28.0%] v 36 [14.3%], p = 0.008), and pre-intervention antegrade flow (48 [70.6%] v 104 [41.3%], p < 0.001) were more common in RVOTI. Significant center differences were noted (p < 0.001). Adjusted survival to CR by 18 months (HR = 0.87, 95% CI = 0.63-1.21, p = 0.41) and overall survival (HR = 2.08, 95% CI = 0.93-4.65, p = 0.074) were similar. RVOTI had increased interstage reintervention (HR = 2.15, 95% CI = 1.36-3.99, p = 0.001). Total anesthesia (243 [213, 277] v 328 [308, 351] minutes, p < 0.001) and cardiopulmonary bypass times (117 [103, 132] v 151 [143, 160] minutes, p < 0.001) favored RVOTI. In this multicenter comparison of physiologic palliation strategies for sTOF, survival to successful CR and overall survival were similar; however, reintervention burden was significantly higher in RVOTI.

Indexed as

Blalock-Taussig ProcedureTetralogy of FallotHumansInfantInfant, NewbornPalliative CarePulmonary ArteryRetrospective StudiesTreatment OutcomeBlalock–Taussig–Thomas ShuntCongenital heart diseaseRight ventricle outflow tract interventionTetralogy of Fallot

Identifiers

PMID35381860
OpenAlexW4226002150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.